Glimzab MV 1mg/500mg/0.3mg Tablet ER
Manufacturer
Neucure Lifesciences Private Limited
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)
Key Information
Short Description
Glimzab MV 1mg/500mg/0.3mg Tablet ER is a combination of medicines used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Dosage Form
Tablet ER
Introduction
Glimzab MV 1mg/500mg/0.3mg Tablet ER belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Directions for Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimzab MV 1mg/500mg/0.3mg Tablet ER is to be taken empty stomach.
How it works
Glimzab MV 1mg/500mg/0.3mg Tablet ER is a combination of three antidiabetic medicines:
Quick Tips
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Related Medicines
Trivolib Forte 1 Tablet
Trivoglicad 1mg/500mg/0.3mg Tablet ER
Trivose 1 Tablet ER
Wonvog Trio 1 Tablet ER
Switmet-GV 1 Tablet ER
Glipament MV 1 Tablet ER
Gevel Trio 1 Tablet ER
Trivose 1mg/500mg/0.3mg Tablet ER
Frequently asked questions
What is Glimzab MV 1mg/500mg/0.3mg Tablet ER?
Glimzab MV 1mg/500mg/0.3mg Tablet ER is a combination of three medicines: Glimepiride, Metformin and Voglibose. This medicine is used in the treatment of type 2 diabetes mellitus (DM). It improves blood glucose levels in adults when taken along with proper diet and regular exercise. Glimepiride lowers blood glucose levels by increasing insulin release from the pancreas. Metformin works by reducing glucose production in the liver and improving insulin sensitivity. Voglibose is an alpha-glucosidase inhibitor that lowers postprandial (after meals) glucose levels. This combination is not indicated for the treatment of Type 1 DM.
What are the possible side effects of Glimzab MV 1mg/500mg/0.3mg Tablet ER?
Common side effects of Glimzab MV 1mg/500mg/0.3mg Tablet ER include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash and respiratory tract infection.
Are there any specific conditions in which Glimzab MV 1mg/500mg/0.3mg Tablet ER should not be taken?
Avoid use of Glimzab MV 1mg/500mg/0.3mg Tablet ER in patients with known allergy to any component or excipient of this medicine. Use is also avoided in patients with moderate to severe kidney disease and inflammatory bowel disease, colonic ulcerations and underlying metabolic acidosis including diabetic ketoacidosis.
Is it safe to take alcohol while I am also taking Glimzab MV 1mg/500mg/0.3mg Tablet ER?
No, combining Glimzab MV 1mg/500mg/0.3mg Tablet ER with alcohol is not recommended as this may lower blood sugar levels (hypoglycemia) and increase the risk of lactic acidosis.
Can the use of Glimzab MV 1mg/500mg/0.3mg Tablet ER cause hypoglycemia?
Yes, Glimzab MV 1mg/500mg/0.3mg Tablet ER can cause hypoglycemia (low blood sugar level). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. This is more likely to occur if you miss meals, drink alcohol, over-exercise, or take other antidiabetic medications concurrently.
What are the instructions for the storage and disposal of Glimzab MV 1mg/500mg/0.3mg Tablet ER?
Store this medication in its original container, tightly closed. Follow the instructions on the packaging label regarding its storage period. Dispose of unused medication properly. Ensure it is not consumed by pets, children or other individuals.
